J Urol 2020 Apr
Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
Related Questions
What neoadjuvant or adjuvant therapy would you give?
New answer by Medical Oncologist at University of Washington School of Medicine (February 7, 2021)
The risk of clinical under-staging is notorious in UTUC; therefore, we aim to maximize control of disease and address the meaningful risk of micro-metastasis. In that context ...
Would T or N group change your recommendation?
New comment by Medical Oncologist at University of Washington School of Medicine ( April 25, 2022)
Good question but probably not much due to the different tumor types. Would ideally wait for more data in urothelial Ca for that question, especially in the adjuvant setting, ...
Since the benefit of neoadjuvant chemotherapy is well-defined in muscle-invasive bladder cancer, is it reasonable to consider this in upper-tract tumo...
New comment by Medical Oncologist at University of Tennessee Health Science Center ( October 22, 2024)
If a patient has a solitary kidney and has high-grade T3 papillary urothelial of the kidney, would you consider GemCis? He is bound to be on dialysis post resection so does th...